Compile Data Set for Download or QSAR
maximum 50k data
Found 232 with Last Name = 'nylöf' and Initial = 'm'
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090771((R)-1-[3-(Isopropyl-propyl-amino)-chroman-5-yl]-et...)
Affinity DataKi:  0.300nMAssay Description:In vitro binding affinity at 5-HT1A receptors assayed by displacement of [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membr...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090762((R)-3-(Isopropyl-propyl-amino)-chroman-5-carboxyli...)
Affinity DataKi:  0.320nMAssay Description:In vitro binding affinity at 5-HT1A receptors assayed by displacement of [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membr...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090763((R)-3-{[4-(7,9-Dioxo-8-aza-spiro[4.5]dec-8-yl)-but...)
Affinity DataKi:  0.340nMAssay Description:In vitro binding affinity at 5-HT1A receptors assayed by displacement of [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membr...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090756((R)-3-(Cyclopentyl-propyl-amino)-chroman-5-carboxy...)
Affinity DataKi:  0.410nMAssay Description:In vitro binding affinity at 5-HT1A receptors assayed by displacement of [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membr...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090764((R)-3-(Isopropyl-propyl-amino)-chroman-5-carboxyli...)
Affinity DataKi:  0.480nMAssay Description:In vitro binding affinity at 5-HT1A receptors assayed by displacement of [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membr...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090772((R)-3-(Isobutyl-propyl-amino)-chroman-5-carboxylic...)
Affinity DataKi:  2.37nMAssay Description:In vitro binding affinity at 5-HT1A receptors assayed by displacement of [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membr...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090770((R)-Isopropyl-(5-methoxy-chroman-3-yl)-propyl-amin...)
Affinity DataKi:  3.10nMAssay Description:In vitro binding affinity at 5-HT1A receptor by measuring its ability to displace [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090771((R)-1-[3-(Isopropyl-propyl-amino)-chroman-5-yl]-et...)
Affinity DataKi:  11.9nMAssay Description:In vitro binding affinity at 5-HT1A receptors assayed by displacement of [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membr...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090759((R)-3-Dipropylamino-chroman-5-carboxylic acid isop...)
Affinity DataKi:  14nMAssay Description:In vitro binding affinity at 5-HT1A receptors assayed by displacement of [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membr...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090761((R)-3-(Cyclopentyl-propyl-amino)-chroman-5-carboxy...)
Affinity DataKi:  18.5nMAssay Description:In vitro binding affinity at 5-HT1A receptors assayed by displacement of [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membr...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090759((R)-3-Dipropylamino-chroman-5-carboxylic acid isop...)
Affinity DataKi:  64nMAssay Description:In vitro binding affinity at 5-HT1A receptor by measuring its ability to displace [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090754((R)-3-Propylamino-chroman-5-carboxylic acid amide ...)
Affinity DataKi:  98.4nMAssay Description:In vitro binding affinity at 5-HT1A receptors assayed by displacement of [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membr...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090770((R)-Isopropyl-(5-methoxy-chroman-3-yl)-propyl-amin...)
Affinity DataKi:  134nMAssay Description:In vitro binding affinity at 5-HT1A receptor by measuring its ability to displace [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocam...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 1A(Rattus norvegicus (rat))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090757((R)-3-Isopropylamino-chroman-5-carboxylic acid ami...)
Affinity DataKi:  397nMAssay Description:In vitro binding affinity at 5-HT1A receptors assayed by displacement of [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membr...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2A(Rattus norvegicus (rat))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090754((R)-3-Propylamino-chroman-5-carboxylic acid amide ...)
Affinity DataKi: >1.00E+3nMAssay Description:In vitro binding affinity at 5-hydroxytryptamine 2A receptor by displacement of [3H]-ketanserin from rat cortexMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2A(Rattus norvegicus (rat))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090759((R)-3-Dipropylamino-chroman-5-carboxylic acid isop...)
Affinity DataKi: >1.00E+3nMAssay Description:In vitro binding affinity at 5-hydroxytryptamine 2A receptor by displacement of [3H]-ketanserin from rat cortexMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetD(1A) dopamine receptor(RAT)
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090754((R)-3-Propylamino-chroman-5-carboxylic acid amide ...)
Affinity DataKi: >1.00E+3nMAssay Description:In vitro binding affinity at D1 receptor by measuring its ability to displace [3H]-SCH-23,390 from Dopamine receptor D1 in rat striatumMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetD(2) dopamine receptor(Homo sapiens (Human))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090759((R)-3-Dipropylamino-chroman-5-carboxylic acid isop...)
Affinity DataKi: >1.00E+3nMAssay Description:In vitro binding affinity at human cloned Dopamine receptor D2A measured by ability to displace [3H]-raclopride from D2A receptor expressed in mouse ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2A(Rattus norvegicus (rat))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090758((R)-3-(Cyclopentyl-propyl-amino)-chroman-5-carboxy...)
Affinity DataKi: >1.00E+3nMAssay Description:In vitro binding affinity at 5-hydroxytryptamine 2A receptor by displacement of [3H]-ketanserin from rat cortexMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetD(1A) dopamine receptor(RAT)
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090757((R)-3-Isopropylamino-chroman-5-carboxylic acid ami...)
Affinity DataKi: >1.00E+3nMAssay Description:In vitro binding affinity at D1 receptor by measuring its ability to displace [3H]-SCH-23,390 from Dopamine receptor D1 in rat striatumMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2A(Rattus norvegicus (rat))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090757((R)-3-Isopropylamino-chroman-5-carboxylic acid ami...)
Affinity DataKi: >1.00E+3nMAssay Description:In vitro binding affinity at 5-hydroxytryptamine 2A receptor by displacement of [3H]-ketanserin from rat cortexMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetD(2) dopamine receptor(Homo sapiens (Human))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090757((R)-3-Isopropylamino-chroman-5-carboxylic acid ami...)
Affinity DataKi: >1.00E+3nMAssay Description:In vitro binding affinity at human cloned Dopamine receptor D2A measured by ability to displace [3H]-raclopride from D2A receptor expressed in mouse ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetD(1A) dopamine receptor(RAT)
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090764((R)-3-(Isopropyl-propyl-amino)-chroman-5-carboxyli...)
Affinity DataKi: >1.00E+3nMAssay Description:In vitro binding affinity at D1 receptor by measuring its ability to displace [3H]-SCH-23,390 from Dopamine receptor D1 in rat striatumMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetD(2) dopamine receptor(Homo sapiens (Human))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090758((R)-3-(Cyclopentyl-propyl-amino)-chroman-5-carboxy...)
Affinity DataKi: >1.00E+3nMAssay Description:In vitro binding affinity at human cloned Dopamine receptor D2A measured by ability to displace [3H]-raclopride from D2A receptor expressed in mouse ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetD(1A) dopamine receptor(RAT)
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090759((R)-3-Dipropylamino-chroman-5-carboxylic acid isop...)
Affinity DataKi: >1.00E+3nMAssay Description:In vitro binding affinity at D1 receptor by measuring its ability to displace [3H]-SCH-23,390 from Dopamine receptor D1 in rat striatumMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetD(2) dopamine receptor(Homo sapiens (Human))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090754((R)-3-Propylamino-chroman-5-carboxylic acid amide ...)
Affinity DataKi: >1.00E+3nMAssay Description:In vitro binding affinity at human cloned Dopamine receptor D2A measured by ability to displace [3H]-raclopride from D2A receptor expressed in mouse ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2A(Rattus norvegicus (rat))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090764((R)-3-(Isopropyl-propyl-amino)-chroman-5-carboxyli...)
Affinity DataKi: >1.00E+3nMAssay Description:In vitro binding affinity at 5-hydroxytryptamine 2A receptor by displacement of [3H]-ketanserin from rat cortexMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetD(1A) dopamine receptor(RAT)
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090758((R)-3-(Cyclopentyl-propyl-amino)-chroman-5-carboxy...)
Affinity DataKi: >4.00E+3nMAssay Description:In vitro binding affinity at D1 receptor by measuring its ability to displace [3H]-SCH-23,390 from Dopamine receptor D1 in rat striatumMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetD(2) dopamine receptor(Homo sapiens (Human))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090771((R)-1-[3-(Isopropyl-propyl-amino)-chroman-5-yl]-et...)
Affinity DataKi:  3.01E+4nMAssay Description:In vitro binding affinity at human cloned Dopamine receptor D2A by measuring its ability to displace [3H]-raclopride from D2A receptor expressed in m...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetD(2) dopamine receptor(Homo sapiens (Human))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090764((R)-3-(Isopropyl-propyl-amino)-chroman-5-carboxyli...)
Affinity DataKi: >5.00E+4nMAssay Description:In vitro binding affinity at human cloned Dopamine receptor D2A measured by ability to displace [3H]-raclopride from D2A receptor expressed in mouse ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2A(Rattus norvegicus (rat))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50090772((R)-3-(Isobutyl-propyl-amino)-chroman-5-carboxylic...)
Affinity DataKi: >5.00E+4nMAssay Description:In vitro binding affinity at 5-hydroxytryptamine 2A receptor by displacement of [3H]-ketanserin from rat cortexMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50391055(CHEMBL2088399)
Affinity DataIC50:  3.70nMAssay Description:Antagonist activity at human recombinant TRPV1 receptor assessed as inhibition of capsaicin-induced calcium uptake by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50391031(CHEMBL2088393)
Affinity DataIC50:  9.80nMAssay Description:Antagonist activity at human recombinant TRPV1 receptor assessed as inhibition of capsaicin-induced calcium uptake by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50391029(CHEMBL2088391)
Affinity DataIC50:  12nMAssay Description:Antagonist activity at human recombinant TRPV1 receptor assessed as inhibition of capsaicin-induced calcium uptake by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50391491(CHEMBL2147211)
Affinity DataIC50:  25nMAssay Description:Inhibition of human Nav1.7 expressed in HEK293 cells by whole cell voltage-clamp electrophysiology assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50391513(CHEMBL2147306)
Affinity DataIC50:  25nMAssay Description:Inhibition of human Nav1.7 expressed in HEK293 cells by whole cell voltage-clamp electrophysiology assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50391489(CHEMBL2147212)
Affinity DataIC50:  25nMAssay Description:Inhibition of human Nav1.7 expressed in HEK293 cells by whole cell voltage-clamp electrophysiology assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50391027(CHEMBL2088401)
Affinity DataIC50:  27nMAssay Description:Antagonist activity at human recombinant TRPV1 receptor assessed as inhibition of capsaicin-induced calcium uptake by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50391025(CHEMBL2088398)
Affinity DataIC50:  27nMAssay Description:Antagonist activity at human recombinant TRPV1 receptor assessed as inhibition of capsaicin-induced calcium uptake by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50391483(CHEMBL2147223)
Affinity DataIC50:  32nMAssay Description:Inhibition of human Nav1.7 expressed in HEK293 cells by whole cell voltage-clamp electrophysiology assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50391496(CHEMBL2147221)
Affinity DataIC50:  32nMAssay Description:Inhibition of human Nav1.7 expressed in HEK293 cells by whole cell voltage-clamp electrophysiology assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50391502(CHEMBL2147305)
Affinity DataIC50:  32nMAssay Description:Inhibition of human Nav1.7 expressed in HEK293 cells by whole cell voltage-clamp electrophysiology assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50391032(CHEMBL2088394)
Affinity DataIC50:  33nMAssay Description:Antagonist activity at human recombinant TRPV1 receptor assessed as inhibition of capsaicin-induced calcium uptake by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50391492(CHEMBL2147213)
Affinity DataIC50:  40nMAssay Description:Inhibition of human Nav1.7 expressed in HEK293 cells by whole cell voltage-clamp electrophysiology assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50391501(CHEMBL2147307)
Affinity DataIC50:  40nMAssay Description:Inhibition of human Nav1.7 expressed in HEK293 cells by whole cell voltage-clamp electrophysiology assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50391040(CHEMBL2088406)
Affinity DataIC50:  41nMAssay Description:Antagonist activity at human recombinant TRPV1 receptor assessed as inhibition of capsaicin-induced calcium uptake by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50391052(CHEMBL2088419)
Affinity DataIC50:  47nMAssay Description:Antagonist activity at human recombinant TRPV1 receptor assessed as inhibition of capsaicin-induced calcium uptake by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50391500(CHEMBL2147308)
Affinity DataIC50:  50nMAssay Description:Inhibition of human Nav1.7 expressed in HEK293 cells by whole cell voltage-clamp electrophysiology assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50391053(CHEMBL2088420)
Affinity DataIC50:  52nMAssay Description:Antagonist activity at human recombinant TRPV1 receptor assessed as inhibition of capsaicin-induced calcium uptake by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50391037(CHEMBL2088403)
Affinity DataIC50:  52nMAssay Description:Antagonist activity at human recombinant TRPV1 receptor assessed as inhibition of capsaicin-induced calcium uptake by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 232 total ) | Next | Last >>
Jump to: